P2Y12 inhibition should be started at the time of NSTEMI diagnosis - CON.
Topic:
Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Speaker:
Professor G. Montalescot (Paris, FR)
Event:
ESC Congress 2019
Congress Presentation
About the speaker
Professor Gilles Montalescot
Pitie Salpetriere APHP University Hospital, Paris (France)
32
presentations
1
follower
5 more presentations in this session
Access the full session
Controversies in anti-platelet therapy
Speakers:
Professor G. Montalescot, Professor M. Valgimigli, Doctor M. Bonaca, Associate Professor G. De Luca
About the event
ESC 365 is supported by
